The LightPod V650 improves upon the gold-standard devices for vascular lesions by eliminating the limitations and potential risks that traditional technologies incurred. The 1064nm wavelength’s depth of penetration gives the LightPod V650 an advantage over the shorter wavelength devices.
The addition of 650-microsecond technology negates the pain and adverse effects typically associated with long-pulsed Nd:YAG lasers as well as the risk of epidermal burns from PDL and KTP lasers. This enables it to effectively and safely treat a range of vascular lesions, such as deep and superficial vessels, thick lesions and plaques and diffuse redness, all within a comfortable treatment that does not require skin cooling or anesthetic. 914-345-8300, http://aerolase.com